Companies / BOC Sciences / Blosozumab
BOC Sciences

Blosozumab | BOC Sciences

Blosozumab is a recombinant monoclonal antibody binding to sclerostin (SOST). Blosozumab could be used as a target drug to improve bone mineral density in postmenopausal women.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.